Windtree Therapeutics, Inc. (WINT) Appoints Leanne Kelly to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
January 13, 2025 8:00 AM ESTWARRINGTON, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (Windtree or the Company) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced the appointment of Leanne Kelly to its board of directors (Board). Ms. Kelly has significant public company executive experience and joins the Board as an independent director and chair of the audit committee.
Ms. Kelly has served as GRI Bios Chief Financial Officer since April 2023. She brings over 20 years of experience leading private and publicly traded companies across life science,... More
